Carisma Therapeutics

Philadelphia, United States · Founded 2016 · $142.0M raised

Founded
2016
Business Model
B2B
Total Funding
$142.0M
Last Round
$30.0M Series CSep 2022
Rounds
3

About

Carisma Therapeutics is a clinical-stage biopharmaceutical company developing cell therapies based on engineered macrophages and monocytes. Its proprietary platform uses chimeric antigen receptors to direct these innate immune cells against tumor-associated antigens, with initial programs targeting solid tumors. The platform was developed in collaboration with the University of Pennsylvania and is intended to create immunotherapies for cancer and other serious diseases.

Summary

Carisma Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2016. It has raised $142.0M in total across 3 rounds, most recently a $30.0M Series C round in Sep 2022. Investors include SymBiosis II, AbbVie Ventures and HealthCap.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CSep 2022
$30.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Carisma Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/carisma-therapeutics"><img src="https://indexed.vc/api/badge/company/carisma-therapeutics" alt="Carisma Therapeutics on Indexed.vc" width="260" height="76" /></a>